Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors

By Eglen Richard M   Reisine Terry  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 3, 2010-03 ,pp. : 277-290

Informa Healthcare

Access to resources Recommend Favorite

Kinase Chemogenomics: Targeting the Human Kinome for Target Validation and Drug Discovery

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : 235-253

Bentham Science Publishers

Access to resources Recommend Favorite

Human Chorionic Gonadotropin: A Model Molecule For Oligopeptide-Based Drug Discovery

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 1, 2011-03 ,pp. : 32-53

Bentham Science Publishers

Access to resources Recommend Favorite

Cheminfomatic-based Drug Discovery of Human Tyrosine Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 13, 2016-05 ,pp. : 1452-1462

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in tau-based drug discovery

By Noble Wendy   Pooler Amy M   Hanger Diane P  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 8, 2011-08 ,pp. : 797-810

Informa Healthcare

Access to resources Recommend Favorite